Optical Coherence Tomography for EVERolimus Eluting STent (OCTEVEREST).

Trial Profile

Optical Coherence Tomography for EVERolimus Eluting STent (OCTEVEREST).

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Oct 2015

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms OCTEVEREST
  • Most Recent Events

    • 14 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 31 Jul 2013 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified Jun 2010).
    • 21 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top